These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3755325)

  • 1. The likelihood ratio. An improved measure for reporting and evaluating diagnostic test results.
    Radack KL; Rouan G; Hedges J
    Arch Pathol Lab Med; 1986 Aug; 110(8):689-93. PubMed ID: 3755325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpretation of diagnostic data: 5. How to do it with simple maths.
    Can Med Assoc J; 1983 Nov; 129(9):947-54. PubMed ID: 6671182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic utility of multiple-level likelihood ratios.
    Bowden SC; Loring DW
    J Int Neuropsychol Soc; 2009 Sep; 15(5):769-76. PubMed ID: 19635177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the gain in diagnostic performance when combining two diagnostic tests.
    Macaskill P; Walter SD; Irwig L; Franco EL
    Stat Med; 2002 Sep; 21(17):2527-46. PubMed ID: 12205697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the likelihood ratio in the management of the young child with fever.
    Pascoe JM
    J Fam Pract; 1986 Apr; 22(4):349-52. PubMed ID: 3958681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpretation of diagnostic data: 2. How to do it with a simple table (part A).
    Can Med Assoc J; 1983 Sep; 129(6):559-64. PubMed ID: 6883257
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictive value and efficiency of hematology data.
    Galen RS
    Blood Cells; 1980; 6(2):185-97. PubMed ID: 6769520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Criteria for evaluating the performance and utility of a diagnostic test].
    Mancini J; Gaudart J; Giorgi R
    Med Trop (Mars); 2009 Feb; 69(1):78-82. PubMed ID: 19499742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the predictive value model in the analysis of test effectiveness.
    Galen RS
    Clin Lab Med; 1982 Dec; 2(4):685-99. PubMed ID: 7160151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advantages to transforming the receiver operating characteristic (ROC) curve into likelihood ratio co-ordinates.
    Johnson NP
    Stat Med; 2004 Jul; 23(14):2257-66. PubMed ID: 15236429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding diagnostic tests 2: likelihood ratios, pre- and post-test probabilities and their use in clinical practice.
    Akobeng AK
    Acta Paediatr; 2007 Apr; 96(4):487-91. PubMed ID: 17306009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of a chest pain diagnostic protocol to exclude acute cardiac ischemia in the emergency department.
    Zalenski RJ; McCarren M; Roberts R; Rydman RJ; Jovanovic B; Das K; Mendez J; el-Khadra M; Fraker L; McDermott M
    Arch Intern Med; 1997 May; 157(10):1085-91. PubMed ID: 9164374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicentre evaluation of an immunological rapid test for the detection of troponin T in whole blood samples.
    Collinson PO; Gerhardt W; Katus HA; Müller-Bardorff M; Braun S; Schricke U; Vogt W; Nagel D; Zander M; Leinberger R; Mangold D; Zerback R
    Eur J Clin Chem Clin Biochem; 1996 Jul; 34(7):591-8. PubMed ID: 8864412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using population-based serum drug concentration cutoff values to predict toxicity: test performance and limitations compared with Bayesian interpretation.
    Schumacher GE; Barr JT
    Clin Pharm; 1990 Oct; 9(10):788-96. PubMed ID: 2242660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Total creatine kinase (CK), CK-2 and myoglobin in the diagnosis of acute myocardial infarct in an emergency service].
    Latour Pérez J; Alvarez do Barrio M; Estellés Herrero MA; Graells Ferrer ML
    Med Clin (Barc); 1993 May; 100(17):641-5. PubMed ID: 8497168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of creatine kinase and creatine kinase-MB for diagnosing myocardial infarction. Clinical impact in the emergency room.
    Lee TH; Weisberg MC; Cook EF; Daley K; Brand DA; Goldman L
    Arch Intern Med; 1987 Jan; 147(1):115-21. PubMed ID: 3800513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporating uncertainty into medical decision making: an approach to unexpected test results.
    Bianchi MT; Alexander BM; Cash SS
    Med Decis Making; 2009; 29(1):116-24. PubMed ID: 18812583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of cardiac troponin I in patients with acute myocardial infarction and unstable angina.
    Selim NA; Hmouda HT
    Saudi Med J; 2002 May; 23(5):526-8. PubMed ID: 12070573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very early diagnosis and risk stratification of patients admitted with suspected acute myocardial infarction by the combined evaluation of a single serum value of cardiac troponin-T, myoglobin, and creatine kinase MB(mass).
    Jurlander B; Clemmensen P; Wagner GS; Grande P
    Eur Heart J; 2000 Mar; 21(5):382-9. PubMed ID: 10666352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two radioimmunoassays compared with isoenzyme electrophoresis for the detection of serum creatine kinase-MB in acute myocardial infarction.
    Witherspoon LR; Shuler SE; Genre CF; Mackenzie FJ; Garcia MM
    J Nucl Med; 1982 Feb; 23(2):136-42. PubMed ID: 7057255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.